...
首页> 外文期刊>BMC Nephrology >Diabetic nephropathy in a sibling and albuminuria predict early GFR decline: a prospective cohort study
【24h】

Diabetic nephropathy in a sibling and albuminuria predict early GFR decline: a prospective cohort study

机译:兄弟姐妹和白蛋白尿中的糖尿病肾病预测,早期GFR衰退:一个未来的队列研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Diabetic nephropathy is a growing clinical problem, and the cause for >40% of incident ESRD cases. Unfortunately, few modifiable risk factors are known. The objective is to examine if albuminuria and history of diabetic nephropathy (DN) in a sibling are associated with early DN progression or mortality. Methods In this longitudinal study of adults >18?yrs with diabetes monitored for up to 9?yrs (mean 4.6?±?1.7?yrs), 435 subjects at high risk (DN family history) and 400 at low risk (diabetes >10?yrs, normoalbuminuria, no DN family history) for DN progression were evaluated for rate of eGFR change using the linear mixed effects model and progression to ESRD. All-cause mortality was evaluated by Kaplan-Meier analyses while controlling for baseline covariates in a Cox proportional hazards model. Covariates included baseline eGFR, age, gender, race, diabetes duration, blood pressure, hemoglobin A1c and urine albumin:creatinine ratio. Propensity score matching was used to identify high and low risk group pairs with balanced covariates. Sensitivity analyses were employed to test for residual confounding. Results Mean baseline eGFR was 74?ml/min/1.73?m2 (86% of cohort >60?ml/min/1.73?m2). Thirty high risk and no low risk subjects developed ESRD. eGFR decline was significantly greater in high compared to low risk subjects. After controlling for confounders, change in eGFR remained significantly different between groups, suggesting that DN family history independently regulates GFR progression. Mortality was also significantly greater in high versus low risk subjects, but after controlling for baseline covariates, no significant difference was observed between groups, indicating that factors other than DN family history more strongly affect mortality. Analyses of the matched pairs confirmed change in eGFR and mortality findings. Sensitivity analyses demonstrated that the eGFR results were not due to residual confounding by unmeasured covariates of a moderate effect size in the propensity matching. Conclusions Diabetic subjects with albuminuria and family history of DN are vulnerable for early GFR decline, whereas subjects with diabetes for longer than 10?years, normoalbuminuria and negative family history, experience slower eGFR decline, and are extremely unlikely to require dialysis. Although we would not recommend that patients with low risk characteristics be neglected, scarce resources would be more sensibly devoted to vulnerable patients, such as the high risk cases in our study, and preferably prior to the onset of albuminuria or GFR decline.
机译:背景技术糖尿病肾病是一种日益增长的临床问题,其原因> 40%的入射ESRD病例。不幸的是,很少有可修改的风险因素是已知的。目的是检查兄弟姐妹中糖尿病肾病(DN)的白蛋白尿和历史是否与早期DN进展或死亡率相关。在该成人的这种纵向研究中的方法> 18?YRS与糖尿病监测,最多9?YRS(平均4.6?±1.7?YRS),435名受试者,高风险(DN家族历史)和400个低风险(糖尿病> 10使用线性混合效应模型和对ESRD的进展评估DN进展的YRS,Normoalbuminuria,NO DN系列历史)用于EGFR改变的速率。 Kaplan-Meier分析评估了全因死亡率,同时控制Cox比例危险模型中的基线协变量。协变量包括基线EGFR,年龄,性别,种族,糖尿病持续时间,血压,血红蛋白A1C和尿白蛋白:肌酐比率。倾向得分匹配用于识别具有平衡协变量的高低风险组对。使用敏感性分析来测试残留混杂。结果意味着基线EGFR为74?ml / min / 1.73?m 2 (86%的坐孔> 60?ml / min /1.73Ωm 2 )。风险三十个高风险,没有低风险科目开发了ESRD。与低风险受试者相比,EGFR下降明显大大。在控制混淆后,在群体之间的EGFR的变化仍然有显着差异,表明DN家族史独立地调节GFR进展。高与低风险受试者的死亡率也明显更大,但在控制基线协变量之后,群体之间没有观察到显着差异,表明DN家族历史以外的因素会影响死亡率。匹配对的分析确认了EGFR和死亡率调查结果的变化。敏感性分析表明,EGFR结果不是由于在倾向匹配中的中等效果大小的未测量协变量的残余混淆。结论糖尿病患者和DN家族历史的糖尿病受试者易受高于GFR衰退的影响,而糖尿病的受试者超过10?年,Normoalbuminuria和负家庭历史,体验较慢的EGFR下降,并且极其不太可能需要透析。虽然我们不建议忽视风险特征低的患者,但稀缺的资源将更明智地致力于脆弱的患者,例如我们研究的高风险案件,优选在蛋白核尿或GFR下降之前。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号